112 related articles for article (PubMed ID: 12956062)
1. Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms.
Hakimelahi GH; Li PC; Moosavi-Movahedi AA; Chamani J; Khodarahmi GA; Ly TW; Valiyev F; Leong MK; Hakimelahi S; Shia KS; Chao I
Org Biomol Chem; 2003 Jul; 1(14):2461-7. PubMed ID: 12956062
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of an electronically activated isooxacephem.
Hakimelahi GH; Tsay SC; Tso HH; Ramezani Z; Hwu JR
Bioorg Med Chem; 1996 Aug; 4(8):1361-4. PubMed ID: 8879559
[TBL] [Abstract][Full Text] [Related]
3. Cephalosporin 3'-phloroglucide esters and 7-(phloroglucidamido) cephalosporins as novel antibacterial agents.
Hwu JR; Moshfegh AA; Tsay SC; Lin CC; Tseng WN; Azaripour A; Mottaghian H; Hakimelahi GH
J Med Chem; 1997 Oct; 40(21):3434-41. PubMed ID: 9341918
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
Sutherland CA; Nicolau DP
Clin Ther; 2015 Jul; 37(7):1564-71. PubMed ID: 26088525
[TBL] [Abstract][Full Text] [Related]
5. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
Saionji K
Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
[TBL] [Abstract][Full Text] [Related]
6. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
Rogers DT; Russell AD
J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
[No Abstract] [Full Text] [Related]
7. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
8. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.
Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF
BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061
[TBL] [Abstract][Full Text] [Related]
9. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
[TBL] [Abstract][Full Text] [Related]
10. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
12. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of 7 beta-[1-(2-aminothiazol-4-yl)-1-cyclopropanecarboxyamido]cephem derivatives.
Nishimura S; Yasuda N; Sasaki H; Sakane K; Takaya T
J Antibiot (Tokyo); 1990 Oct; 43(10):1278-85. PubMed ID: 2124209
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial susceptibility and beta-lactamase types among clinical isolates during January and February 2000 in the Kinki area of Japan].
Yamasaki K; Nishio H; Komatsu M; Satoh K; Yamashita T; Washidu R; Shimakawa K; Kinoshita S; Ura T; Aihara M
Jpn J Antibiot; 2002 Sep; 55 Suppl A():65-78. PubMed ID: 12599530
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
[TBL] [Abstract][Full Text] [Related]
17. 3-[(1,2,3-Thiadiazol-5-ylthio)methyl]cephalosporins.
Lewis GS; Nelson PH
J Med Chem; 1979 Oct; 22(10):1214-8. PubMed ID: 117106
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
[TBL] [Abstract][Full Text] [Related]
19. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
Yokota T; Yoshida R; Utsui Y; Tajima M
Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibiotic activity of 11 beta-lactam antibiotics in a cancer center.
Landoy Z; Roisilin C; Surgalla MJ; Botzer R; Fitzpatrick JE; Blumenson LE
J Surg Oncol; 1985 Sep; 30(1):23-5. PubMed ID: 3935872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
